SCHEMBL8409769

SCHEMBL8409769

CCc1cc(O)cc(C)c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
HTT P42858 2/20 0.49
MAPT P10636 1/20 0.49
POLB P06746 2/20 0.39
NOS3 P29474 1/20 0.39
NOS1 P29475 1/20 0.39
NOS2 P35228 1/20 0.39
CYP3A4 P08684 5/20 0.39
CHRM1 P11229 1/20 0.39
ALOX15 P16050 1/20 0.39
MAOA P21397 1/20 0.39
TBXA2R P21731 1/20 0.39
ADRA1A P35348 1/20 0.39
HTR2B P41595 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
ACHE P22303 2/20 0.36
CA12 O43570 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10382471 0.86 POLB (0.50) ALDH1A1HTTMAPTPOLBNOS3
SCHEMBL11700695 0.83 PTPN1 (0.44) ALDH1A1HTTMAPTCYP3A4CHRM1
SCHEMBL28505038 0.80 PTPN1 (0.44) HTTPOLBCYP3A4ALOX15TDP1
SCHEMBL282802 0.78 ALDH1A1 (0.58) ALDH1A1MAPTPOLBCYP3A4CHRM1
SCHEMBL12964339 0.77 CYP3A4 (0.42) ALDH1A1POLBCYP3A4CHRM1ALOX15
SCHEMBL2038792 0.77 ALDH1A1 (0.52) ALDH1A1HTTMAPTPOLBNOS3
SCHEMBL70083 0.77 CYP3A4 (0.42) ALDH1A1POLBCYP3A4CHRM1ALOX15
SCHEMBL11529244 0.77 CYP3A4 (0.42) ALDH1A1POLBCYP3A4CHRM1ALOX15
SCHEMBL5158799 0.77 ALDH1A1 (0.52) ALDH1A1HTTMAPTPOLBNOS3
SCHEMBL31553268 0.77 CYP3A4 (0.42) ALDH1A1POLBCYP3A4CHRM1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114977-A1 S1PR4 RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF TIAKI THERAPEUTICS, INC. (US) 2023-06-22 WO disclosed
EP-0446173-B1 Immunoassay for metolachlorine NOVARTIS AG (CH) 1999-07-14 EP disclosed
US-5576188-A HYBRIDOMA CELL LINE WHICH PRODUCES A MONOCLONAL ANTIBODY HAVING SPECIFIED CHARACTERISTICS CIBA-GEIGY CORPORATION (US) 1996-11-19 US disclosed
EP-0446173-A2 Immunoassay for metolachlorine CIBA-GEIGY AG (CH) 1991-09-11 EP disclosed
US-4866079-A INSECTICIDES, MITICIDES CIBA-GEIGY CORPORATION (US) 1989-09-12 US disclosed
EP-0239535-A2 N-pyridyloxyphenyl isothiourea, their preparation and use as pesticides CIBA-GEIGY AG (CH) 1987-09-30 EP disclosed
US-4147804-A ANTIARRHYTHMIA AGENTS WILLIAM H. RORER, INC. (US) 1979-04-03 US disclosed
US-4094861-A Process for the production of non-inflammable polytriazines BAYER AKTIENGESELLSCHAFT (DT) 1978-06-13 US disclosed
US-4059567-A High molecular weight polytriazines of soluble polymeric N-cyano-isourea ethers BAYER AKTIENGESELLSCHAFT (DT) 1977-11-22 US disclosed